EDGAR Filing Documents for 0000935836-17-000264

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0000935836-17-000264

Filing Date

2017-05-19

Accepted

2017-05-19 16:40:03

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		cumberland13g.htm	SC 13G	55999
	Complete submission text file	0000935836-17-000264.txt		57466

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203

Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068

CUMBERLAND PHARMACEUTICALS INC (Subject) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-85205 | Film No.: 17858471
SIC: 2834 Pharmaceutical Preparations

Mailing Address 919 NW BOND STREET SUITE 204 BEND OR 97703

Business Address 919 NW BOND STREET SUITE 204 BEND OR 97703 541.647.5664

Stonepine Capital Management, LLC (Filed by) CIK: 0001440771 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G